The GTPase and kinase activity of the LRRK2 protein are both required for inclusion formation and cell toxicity in cell culture models

被引：0
|
作者：
Schweiger, D.
van Doeselaar, M.
Oostra, B.
Bonifati, V.
机构：
来源：
MOVEMENT DISORDERS | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
55
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [31] Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammation
    Munoz, Lenka
    Kavanagh, Madeline E.
    Phoa, Athena F.
    Heng, Benjamin
    Dzamko, Nicolas
    Chen, Ew-Jun
    Doddareddy, Munikumar Reddy
    Guillemin, Gilles J.
    Kassiou, Michael
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 95 : 29 - 34
  • [32] Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity
    An Phu Tran Nguyen
    Tsika, Elpida
    Kelly, Kaela
    Levine, Nathan
    Chen, Xi
    West, Andrew B.
    Boularand, Sylviane
    Barneoud, Pascal
    Moore, Darren J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (29) : 17296 - 17307
  • [33] LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson's disease
    Keeney, Matthew T.
    Rocha, Emily M.
    Hoffman, Eric K.
    Farmer, Kyle
    Di Maio, Roberto
    Weir, Julie
    Wagner, Weston G.
    Hu, Xiaoping
    Clark, Courtney L.
    Castro, Sandra L.
    Scheirer, Abigail
    Fazzari, Marco
    De Miranda, Briana R.
    Pintchovski, Sean A.
    Shrader, William D.
    Pagano, Patrick J.
    Hastings, Teresa G.
    Greenamyre, J. Timothy
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (767)
  • [34] Identification of a critical region within LRRK2 that mediates the interaction with the cell death adaptor protein FADD
    Antoniou, N.
    Valkimadi, P.
    Rideout, H.
    MOVEMENT DISORDERS, 2011, 26 : S13 - S13
  • [35] GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease
    Ito, Genta
    Okai, Takuro
    Fujino, Go
    Takeda, Kohsuke
    Ichijo, Hidenori
    Katada, Toshiaki
    Iwatsubo, Takeshi
    BIOCHEMISTRY, 2007, 46 (05) : 1380 - 1388
  • [36] Identification of chemicals to inhibit the kinase activity of leucine-rich repeat kinase 2 (LRRK2), a Parkinson's disease-associated protein
    Yun, HyeJin
    Heo, Hye Young
    Kim, Hyun Ha
    DooKim, Nam
    Seol, Wongi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (10) : 2953 - 2957
  • [37] Mutant LRRK2 and Cell Death-Signaling Complex Formation: Implications for Neurodegeneration in Parkinson's Disease
    Rideout, Hardy J.
    Antoniou, Nasia
    Valkimadi, Polena
    Dauer, William T.
    NEUROLOGY, 2010, 74 (09) : A3 - A3
  • [38] Protein Kinase A Activity and Anchoring Are Required for Ovarian Cancer Cell Migration and Invasion
    McKenzie, Andrew J.
    Campbell, Shirley L.
    Howe, Alan K.
    PLOS ONE, 2011, 6 (10):
  • [39] Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase
    Lis, Pawel
    Burel, Sophie
    Steger, Martin
    Mann, Matthias
    Brown, Fiona
    Diez, Federico
    Tonelli, Francesca
    Holton, Janice L.
    Ho, Philip Winglok
    Ho, Shu-Leong
    Chou, Meng-Yun
    Polinski, Nicole K.
    Martinez, Terina N.
    Davies, Paul
    Alessi, Dario R.
    BIOCHEMICAL JOURNAL, 2018, 475 : 1 - 22
  • [40] Neural stem cell culture model for LRRK2 function determines regulation of dopaminergic and microtubule-associated genes
    Meyer, Anne K.
    Sampathkumar, Charanya
    Fransecky, Lars
    Maisel, Martina
    Kissenkoetter, Stefan
    Weselek, Grit
    Berndt, Sebastian
    Kirsch, Matthias
    Schwarz, Johannes
    Hermann, Andreas
    Storch, Alexander
    BASAL GANGLIA, 2015, 5 (04) : 71 - 76
12345